Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cangrelor in Resuscitated STEMI Patients Undergoing TTM
NCT03273075Phase 4Unknown
- Sponsor
- Medical University of Vienna
- Start
- Sep 2017
- Primary completion
- May 2021
- Modality
- Nucleic Acid-Directed Small Molecules, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 4 trial of cangrelor in ST elevation myocardial infarction (STEMI), sponsored by Medical University of Vienna. Status: unknown.
02
Drugs
cangrelor
03
Conditions
ST elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on NCT03273075.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03273075.